Hormones as Conversations, Not Causes: The Korean Medical Reading of Endocrinology

The dominant framing of hormones in modern medicine treats them as causes. Low thyroid causes hypothyroidism; the treatment is to add thyroid hormone. Low estrogen causes menopausal symptoms; the treatment is to add estrogen. Low testosterone causes male hypogonadal symptoms; the treatment is to add testosterone. The clinical model is straightforward: identify the missing signal, replace it, observe improvement. This works in many cases, particularly when the deficiency is profound and the replacement is calibrated carefully. It also fails in many other cases, often in patterns that the cause-based framing cannot explain. Patients with normal thyroid labs but classical hypothyroid symptoms. Patients on estrogen replacement who still feel terrible. Patients whose testosterone levels are corrected with replacement but whose energy, libido, and mood do not follow. The pattern suggests that something about the cause-based framing is incomplete. Hormones as conversations — not as causes — is the structural alternative that classical Korean Traditional Medicine (KTM), the traditional healing system of Korea also known as Hanbang (한방), offers, and the alternative aligns with what endocrinology itself is increasingly discovering about how the body actually uses these signaling molecules.

What the Cause-Based Framing Gets Right

The cause-based framing of hormones is not wrong. It captures genuine clinical realities that produce real benefits when applied correctly. A patient with profound thyroid hormone deficiency due to Hashimoto’s thyroiditis genuinely needs replacement therapy. A woman whose ovaries have been surgically removed genuinely benefits from hormone replacement to manage the resulting symptoms. A man with primary testicular failure may genuinely need testosterone supplementation. In these cases, the deficiency is clear, the replacement is necessary, and the cause-based framing produces appropriate treatment.

The framing also works for conditions of hormone excess. Hyperthyroidism, Cushing’s syndrome, hyperprolactinemia — these conditions involve clear hormone excess, and the treatment that lowers the excess to normal range produces clear clinical benefit. The deficiency-and-excess framework, applied to clear-cut deficiencies and excesses, produces appropriate clinical decisions.

Where the framing struggles is in the much larger middle ground. Patients whose hormone levels are within “normal range” but who present with the symptom clusters classically associated with deficiency. Patients whose hormones are corrected to optimal range through replacement but who continue to feel ill. Patients whose symptoms cycle in ways that hormone levels alone do not predict. These cases account for a substantial fraction of the hormone-related clinical encounters in modern practice, and the cause-based framing handles them poorly.

The conventional response has been to refine the framing — measure more hormones, define narrower “optimal” ranges, add additional replacement agents — without questioning the underlying model. The classical Korean framework suggests this is the wrong direction. The problem is not that the cause-based model needs more parameters; it is that the model itself is incomplete.

The Conversation Framing: What Hormones Actually Are

Classical Korean medicine never developed a specific theory of hormones as such — the biochemical concept did not exist in the classical period. What it did develop was a sophisticated theory of inter-organ communication. The Zang-fu system operates as a network of organs that continuously communicate with each other through what classical theory calls 기 (Qi) — the energetic substance that moves information and influence between organs.

When modern endocrinology characterized hormones — molecules produced by one organ that travel through the bloodstream to affect another organ — it identified one specific mechanism through which the classical Qi-based inter-organ communication actually operates. Hormones are not the only signaling system (nerves, immune cells, and other mechanisms also carry inter-organ signals), but they are the most well-characterized one. The classical framework’s claim that organs communicate continuously was correct; the modern framework added molecular specificity to that claim.

Hormones as conversations means treating each hormone not as an upstream cause but as a word in an ongoing dialogue between organs. Thyroid hormone is not just an upstream signal that produces metabolic effects; it is one term in the conversation among the thyroid, the hypothalamus, the pituitary, the liver (which converts T4 to T3), the cellular receptors that respond to thyroid signaling, and the broader network of metabolic effectors. Estrogen is not just an upstream cause of menstrual cycling; it is one term in the conversation among the ovaries, the hypothalamus, the pituitary, the uterus, the breast tissue, and the many receptor-bearing organs throughout the body.

When you treat a word as a cause, you assume that adding more of the word produces more of the meaning. This works in simple cases where the word is genuinely missing — telling someone “hello” when there has been no greeting changes the conversation. It fails in complex cases where the word is present but the context is wrong — saying “hello” louder to someone who is ignoring you does not produce a more responsive conversation. The hormone replacement that fails to produce expected clinical results is often a case of saying the right word in the wrong conversational context.

Where Modern Endocrinology Is Moving Toward the Conversation Model

The cause-based framing of hormones is increasingly being supplemented within mainstream endocrinology by network-based approaches. The recognition that hormones operate in feedback loops with downstream effectors, that receptor sensitivity matters as much as hormone concentration, that interactions between hormones produce effects that no single hormone alone explains — these are all moves toward the conversation framing without explicitly naming it as such.

The thyroid example is instructive. Conventional thyroid management measures TSH (the pituitary signal to the thyroid) and free T4 (the main thyroid output). The interpretation is straightforward: if TSH is high and free T4 is low, the patient is hypothyroid; if TSH is low and free T4 is high, the patient is hyperthyroid. The treatment follows from these measurements.

This framework misses important elements of the actual conversation. Free T3 (the active form of thyroid hormone, derived from T4 conversion in tissues) is often the more clinically relevant measurement, and conversion efficiency varies substantially between patients. Reverse T3 (an inactive metabolite) can be elevated in stress or chronic illness, blocking T3 receptor activity. Thyroid receptor sensitivity at the cellular level varies with cofactor availability (selenium, iodine, iron). The cortisol-thyroid relationship affects how the thyroid signals are received. The entire conversation involves multiple molecules, multiple organs, and multiple feedback dimensions.

Patients whose conventional thyroid labs are “normal” but who present with classical hypothyroid symptoms often have failures somewhere in this broader conversation. The TSH is normal because the pituitary signal is intact. The free T4 is normal because the thyroid is producing it. But the T3 conversion is poor, or the cellular receptor sensitivity is reduced, or the reverse T3 is elevated, or some other element of the conversation is failing. Adding more thyroid hormone (the cause-based intervention) does not fix these failures because the problem is not that the upstream signal is missing.

The integrative endocrinology movement that has emerged over the past two decades is explicitly trying to address this. By measuring the full conversation (T3, reverse T3, receptor cofactors, downstream metabolic markers) rather than just the upstream signal (TSH, T4), clinicians can identify where the conversation is actually failing and intervene at the right point. This is the conversation framing applied to clinical practice, even when it is not labeled as such.

Why Hormone Replacement Often Produces Disappointing Results

The conversation framing explains a pattern that the cause-based framing struggles with: hormone replacement that corrects the measured deficiency without resolving the symptoms.

A menopausal woman with hot flashes, fatigue, and mood disturbance is often offered estrogen replacement on the assumption that low estrogen is the cause of her symptoms. Replacement raises estrogen to premenopausal levels. The hot flashes may improve. The fatigue and mood often do not, or improve only partially. The cause-based framing treats this as a failure of dosing or formulation; the conversation framing treats it as evidence that the symptom cluster involved more of the conversation than just estrogen.

The classical Korean reading of menopausal symptoms includes multiple organ-system patterns. Kidney-yin deficiency (the structural depletion that comes with the 49-year cycle transition). Liver-blood deficiency (the reduced blood storage as reproductive cycling stops). Heart-fire imbalance (the autonomic dysregulation that follows from the broader hormonal shift). Spleen-Qi deficiency (the metabolic slowing that often accompanies the transition). Each of these is part of the broader conversation that is being disrupted by the reproductive system transition. Adding estrogen back into the conversation addresses one term but leaves the rest unaddressed.

Patients who receive a more complete intervention — addressing kidney-yin, liver-blood, heart-fire, and spleen-Qi alongside any appropriate hormone replacement — often experience much better symptom resolution than patients receiving hormone replacement alone. This is not because hormone replacement is wrong; it is because hormone replacement alone addresses only part of the conversation, and the conversation has multiple terms that all need attention.

The same pattern shows up in male testosterone replacement, thyroid optimization, adrenal support, and most other hormonal interventions. The replacement works partially because it addresses one part of the conversation. It works incompletely because the conversation has other parts the replacement does not touch. Adding more of the replaced hormone produces diminishing returns and sometimes new problems; addressing the broader organ-system conversation produces more complete clinical resolution.

The Side Effects of Treating Words Without Context

The conversation framing also helps explain the side effects of hormone therapy that the cause-based framing treats as unexpected. If you give a patient supplemental thyroid hormone to correct a low T4, you might expect the side effects to be limited to thyroid-related issues — palpitations from excess thyroid activity, tremor, weight changes. The actual side effect profile of long-term thyroid replacement is broader. Bone density changes. Cardiovascular effects. Mood changes that do not correlate cleanly with thyroid level. Sleep disturbances. The hormone affects many parts of the conversation, and when you add it without supporting the receiving organs, the conversation gets distorted in unpredictable ways.

Similar patterns appear with estrogen replacement (cardiovascular risk, breast tissue effects, mood effects), testosterone replacement (cardiovascular effects, prostate effects, hematocrit changes), and most other hormone interventions. The side effects are not random; they are the predictable consequences of adding a word to a conversation without supporting the other participants in the conversation.

Classical Korean medicine has always emphasized this. The reason why traditional herbal formulas typically combine multiple herbs is that they are addressing a conversation rather than a single hormone or symptom. A formula for menopausal symptoms might include herbs that support kidney-yin, nourish liver-blood, clear heart-fire, and strengthen spleen-Qi simultaneously. The formula works on the whole conversation, which produces better results and fewer side effects than any single intervention addressing only one organ would produce.

This is methodologically why pharmaceutical research that tests single compounds against placebo systematically underestimates the value of multi-component approaches. The clinical reality is that conversations require multi-component interventions. Single-compound testing optimizes for what can be patented and standardized, not for what produces the best clinical outcomes. The classical herbal formulations work in clinical practice because they address the conversation, even when single-compound trials cannot easily capture that effect.

What This Means for Patients Considering Hormone Therapy

For patients considering hormone replacement therapy or already receiving it, the conversation framing offers several practical implications.

First, the question is not just “what is my hormone level” but “what is the broader organ-system state in which this hormone level is being measured.” A low-normal thyroid in a patient with healthy liver function, adequate cofactor status, and good cellular receptor sensitivity may produce no symptoms at all. The same low-normal thyroid in a patient with compromised liver conversion, depleted cofactors, and chronic stress may produce profound symptoms. The number is the same; the conversation context is different; the appropriate intervention is different.

Second, hormone replacement should typically be paired with broader organ-system support. A woman starting estrogen replacement also benefits from interventions that support kidney-yin, liver-blood, and heart-fire balance — the surrounding conversation. A man starting testosterone replacement benefits from kidney-yang support and broader metabolic optimization. The replacement addresses one term; the surrounding work addresses the conversation; both are usually needed for full clinical benefit.

Third, the goal of hormone therapy should be conversation restoration, not lifelong replacement. Many patients who genuinely benefit from hormone support in the short term can be tapered off as their underlying organ systems recover function. The classical approach is to treat the conversation aggressively when it is dysfunctional and reduce intervention as the conversation restores. The modern approach often defaults to indefinite replacement, which is sometimes correct (in clear primary deficiencies) and sometimes excessive (in patients whose deficiency was secondary to a treatable broader pattern).

In my clinical experience, patients who think about their hormones as parts of conversations rather than as causes of conditions make better decisions about whether and how to use hormone therapy. They are less likely to demand replacement when modest deficiency does not warrant it. They are more likely to seek broader organ-system support alongside any replacement they do receive. They are more likely to taper appropriately when the underlying conversation has restored. The framing produces more thoughtful clinical engagement, which produces better outcomes on average.

Summary

The dominant modern framing treats hormones as upstream causes — measure the deficiency, replace it, observe improvement. This works for clear-cut primary deficiencies but fails for the much larger middle ground of patients whose hormone levels are “normal” but whose symptoms suggest disrupted hormonal function, or whose replacement therapy fails to fully resolve symptoms. Hormones as conversations — the structural alternative classical Korean medicine offers — treats each hormone as one term in an ongoing dialogue between Zang-fu organs. The hormone is not the cause but the language through which organs communicate about the body’s state. Adding a word to a conversation does not produce the desired meaning if the surrounding context is wrong, which is why hormone replacement so often produces partial results. Modern endocrinology is increasingly converging on this view through the recognition that hormones operate in networks with feedback loops, downstream effectors, and complex inter-organ signaling that the deficiency model cannot capture. The clinical implication is that successful hormone-related treatment requires addressing the organ-system conversation as a whole — supporting the organs that produce, receive, and respond to the hormones — rather than only adjusting the hormone level itself. Patients who engage with hormones as parts of conversations rather than as causes of conditions tend to make better treatment decisions and experience better outcomes than patients working from the strict cause-based framing.

Related: Osteocalcin and the Kidney · Jing and the Theory of Surplus